The Minimal Residual Disease Testing Global Market Report 2023, provides comprehensive information on the minimal residual disease testing market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
Learn More On The Minimal Residual Disease Testing Market’s Growth:
As per The Business Research Company’s Minimal Residual Disease Testing Global Market Report 2023, the global minimal residual disease testing market size is expected to grow from $1.22 billion in 2022 to $1.41 billion in 2023 at a compound annual growth rate (CAGR) of 14.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global minimal residual disease testing market size is expected to reach $2.32 billion in 2027 at a CAGR of 13.3%.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=9970&type=smp
Product innovations are a key trend gaining popularity in the minimal residual disease testing market. Major companies operating in the minimal residual disease testing market are innovating new products to sustain their position in the market. For instance, in 2022, Twist Bioscience, a US-based synthetic biology and genomics company, launched Twist MRD Panel to advance research and development in minimal residual disease (MRD) detection in cancer screening. Twist MRD Panel is a customizable panel of genes that can be used to detect very low levels of residual cancer cells in a patient’s blood. The Twist MRD Panel is designed to be highly flexible and customizable that can be integrated into a typical next-generation sequencing (NGS) workflow that can find minimum residual disease (MRD) in just five days.
The minimal residual disease testing market is segmented:
1) By Test Type: DNA – Based Test, RNA- Based Test, Immunological Test
2) By Technology: Flow Cytometry, Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Other Technologies
3) By Application: Hematological Malignancies, Leukemia, Lymphoma, Solid Tumors, Other Application
4) By End User: Hospitals And Specialty Clinics, Diagnostic Laboratories, Academic and Research Institutes, Other End Users
North America was the largest region in the minimal residual disease testing market in 2022.
The table of contents in TBRC’s minimal residual disease testing market report includes:
1. Executive Summary
2. Minimal Residual Disease Testing Market Characteristics
3. Minimal Residual Disease Testing Market Trends And Strategies
4. Minimal Residual Disease Testing Market – Macro Economic Scenario
5. Minimal Residual Disease Testing Market Size And Growth
.
.
.
26. Africa Minimal Residual Disease Testing Market
27. Minimal Residual Disease Testing Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Minimal Residual Disease Testing Market
29. Minimal Residual Disease Testing Market Future Outlook and Potential Analysis
30. Appendix
Top Major Players:
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Tissue microarray refers to high-throughput technology that enables thorough analysis of an antigen's expression across…
Overview and Scope Nutraceutical contract manufacturing services refer to outsourcing the manufacturing and production of…
Thyroid cancer diagnostics refers to a technique to test a lump or nodule responsible for…
Overview and Scope Encapsulation resins refer to materials and resin systems that protect and insulate…
Overview and Scope Messenger ribonucleic acid (mRNA) synthesis raw materials are ribonuclear materials that ensure…
Thrust vector control (TVC), also known as thrust vectoring, refers to the capability of an…